Childhood brain tumor’s “addiction” to common amino acid glutamine could be its weakness

93b2fc1d-edf9-44e5-adcb-331b403a49d2articleimage.jpg

03 Nov 2017 --- Starving a childhood brain tumor of the amino acid glutamine could improve the effect of chemotherapy, according to an early study led by Queen Mary University of London (QMUL) and funded by Children with Cancer UK and the Medical Research Council. The study suggests that a proportion of medulloblastoma are “addicted” to glutamine.

Medulloblastoma is the most common solid primary brain tumor in children and a major cause of mortality in childhood cancers. Current treatments include a combination of surgery, radiotherapy and chemotherapy, and are effective in a majority of cases, but often associated with significant side effects. These side effects include mental and physical disabilities.

“If we can confirm in human patients that a glutamine restriction diet can be tolerated and is effective, it may be possible to use it to reduce the drug doses required to treat a proportion of patients with medulloblastoma,” says first author Maria Niklison-Chirou from QMUL. “This may lead to more patients being cured or allow survivors to have a better quality of life.”

Enhancing the effect of chemotherapy in mice
The study, published in Genes & Development, looked at cells from medulloblastoma patients and mice which had the disease. The researchers studied the metabolic processes that allow the tumor cells to grow, including the absorption of amino acids, with the aim of identifying new approaches to inhibit their growth and enhance current treatments.

The team found that a proportion of medulloblastoma were “addicted” to glutamine – an amino acid which is usually non-essential in normal cells.

They then fed a glutamine-restricted diet to mice with the disease, and found that this enhanced the effect of chemotherapy, and increased the lifespan of mice, even when they were treated with lower doses of chemotherapy.

However, the researchers warn that although these preclinical results are promising, further studies are required to assess whether a similar approach can be applied to human patients.

Cliff O’Gorman, Chief Executive of Children with Cancer UK, which co-funded the study, says: “We welcome these findings, which open up the possibility of kinder, more effective precision treatment for young patients with medullobastoma.”

“Children and young people with this devastating condition face aggressive treatments that can have a long-term impact on their health and well-being,” O’Gorman adds. “It is crucial that we build on encouraging findings like these by investing in further studies and clinical trials to make cutting-edge treatment a reality for young cancer patients in the UK.”

“Medulloblastoma is the most common type of aggressive brain tumor in children, and the MRC is therefore proud to support research into this dreadful disease, including studies that aim to understand the molecular mechanisms that support the growth of such tumors,” says Dr. Mariana Delfino-Machin, MRC Programme Manager for cancer. “Studies of this nature are crucial, early steps in the process of developing more effective treatments that may also reduce the side-effects caused by standard therapies.”

Related Articles

Nutrition & Health News

Plant power: Optimum Nutrition launches brand's first plant-based protein

23 Feb 2018 --- Performance nutrition supplier Optimum Nutrition ("ON") is expanding its Gold Standard protein line with the brand's first plant-based protein powder. Fitting nicely within the trend toward plant-based offerings to suit athletes of all levels, ON Gold Standard 100% Plant has a multisource blend of premium, plant-based protein that delivers a complete profile of essential amino acids, outstanding taste and texture, without any artificial flavors, colors or sweeteners.

Nutrition & Health News

Drink your vitamins: SternVitamin launches micronutrient premix for beverages 

19 Feb 2018 --- A healthy lifestyle is essential to all age groups, and nutrition plays a major role alongside various other components. SternVitamin is now offering beverage manufacturers a novel way to address the topic of health with a new micronutrient premix for healthy bones and heart. SternVitamin notes that the mix picks up on one of the top trends in the beverage market – water-based enriched products. The vegan premix contains vitamins B1, B12, C, K2 and D3. Organic agave syrup powder gives it a slight sweetness, while natural flavors give the drink a “dark berry” taste. It dissolves clear in water and leaves no turbidity. 

Nutrition & Health News

Ultra-processed foods linked to heightened risk of cancer: major BMJ study

15 Feb 2018 --- Although processed foods have long been thought to be significantly less healthy than non-processed foods, an observational study published yesterday in BMJ has added some stark figures to the link between ultra-processed foods and the risk of cancer. The study concluded that a 10 percent increase in the proportion of ultra-processed foods in the diet is associated with increases of 12 percent in the risk of overall cancer and 11 percent in the risk of breast cancer.

Nutrition & Health News

Plant-based foods could slash a country’s healthcare costs by billions of euros, says study

15 Feb 2018 --- Billions of euros could be saved from a country’s annual healthcare bill over the next years if more people followed a plant-based diet. This is according to a new study published in the Journal of Nutrition which looked at the health and economic consequences of two plant-based eating patterns, a diet with a daily portion of soy foods and a Mediterranean-style diet.

Nutrition & Health News

A gold medal for recovery? FrieslandCampina DMV develops innovative casein isolate 

14 Feb 2018 --- FrieslandCampina DMV has introduced their latest innovation in dairy protein ingredients. Micelate Prestige has been launched this week in Europe and is a key addition to the company’s growing portfolio of Performance Nutrition solutions. 

More Articles
URL : http://www.nutritioninsight.com:80/news/childhood-brain-tumors-addiction-to-common-amino-acid-glutamine-could-be-its-weakness.html